Archive for the ‘Watchful waiting’ Category

URO TODAY: Men who choose watchful waiting after diagnosis of prostate cancer face higher risk of death from the disease than those who choose treatment, a Swedish study of nearly 7000 men has shown. READ MORE>

After adjustment for risk category, co-morbidity, and socio-economic status, there was a lower risk of prostate cancer-specific death in the radical prostatectomy and radiotherapy groups compared to active surveillance.

Overall and regardless of treatment strategy, the risk of prostate cancer-specific death at 8.2 years after diagnosis for all 6849 patients was 17%.

Death from competing causes was 17.6% for the active surveillance group, 6.8% for the radical prostatectomy group and 10.9% for the radio therapy group.

Read Full Post »

URO TODAY:  An “uncertainty management” model developed for people being treated for breast or prostate cancer has been revamped for those who chose active surveillance when diagnosed with prostate cancer. READ MORE>

Read Full Post »

URO TODAY: Watchful waiting may not be a wise choice for younger men diagnosed with low risk prostate cancer, a new study suggests.

Our pathologic findings and risk of biochemical recurrence after open radical prostatectomy question the wisdom of active surveillance in men with low-risk disease who have “long” life expectancies. READ MORE>

Read Full Post »

UPI: Prostate cancer patients who refuse treatment don’t do as well as those who choose radiation treatment, US researchers found. READ MORE>

Researchers at Henry Ford Hospital in Detroit found the 10-year overall survival rate for men who chose “watchful waiting” was 51 percent. It was 68 percent for those who had radiation treatment.

URO TODAY: And those on active surveillance are often reluctant to proceed with treatment because they fear erectile dysfunction. READ MORE>

Read Full Post »

URO TODAY: Active surveillance protocols can be valuable when prostate cancer is managed well and treatment is recommended appropriately, according to two recent studies. READ MORE>

Read Full Post »

URO TODAY: What do you do when you’re told you have prostate cancer – get treatment or wait and watch? A bunch of US experts have been debating the pros and cons of active surveillance. READ MORE>

Read Full Post »

NEW PROSTATE CANCER INFOLINK: Evidence is growing that active surveillance – watchful waiting – is a viable option for men diagnosed with prostate cancer, but more long-term data is needed on survival rates. READ MORE>

“…these data – indicating that just 51 (11%) of 470 men in the Johns Hopkins active surveillance series have gone on to have a radical prostatectomy within roughly a 3-year follow-up period – continue to offer strong evidence of the potential of this management technique.

Read Full Post »

Older Posts »